Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

BUY
$42.05 - $47.77 $504 - $573
12 Added 0.23%
5,275 $230,000
Q1 2022

May 02, 2022

BUY
$40.23 - $47.74 $1,850 - $2,196
46 Added 0.88%
5,263 $229,000
Q4 2021

Jan 26, 2022

SELL
$38.88 - $45.31 $48,522 - $56,546
-1,248 Reduced 19.3%
5,217 $230,000
Q3 2021

Nov 12, 2021

BUY
$38.79 - $43.16 $23,855 - $26,543
615 Added 10.51%
6,465 $247,000
Q2 2021

Aug 06, 2021

SELL
$36.52 - $41.46 $27,170 - $30,846
-744 Reduced 11.28%
5,850 $233,000
Q1 2021

May 11, 2021

SELL
$34.27 - $40.01 $2,056 - $2,400
-60 Reduced 0.9%
6,594 $235,000
Q4 2020

Feb 12, 2021

SELL
$34.07 - $39.94 $511,424 - $599,539
-15,011 Reduced 69.29%
6,654 $245,000
Q3 2020

Nov 09, 2020

SELL
$38.11 - $42.99 $185,748 - $209,533
-4,874 Reduced 18.37%
21,665 $815,000
Q2 2020

Aug 11, 2020

SELL
$37.87 - $43.58 $90,016 - $103,589
-2,377 Reduced 8.22%
26,539 $1.08 Million
Q1 2020

May 13, 2020

SELL
$32.47 - $48.83 $58,543 - $88,040
-1,803 Reduced 5.87%
28,916 $1.1 Million
Q4 2019

Feb 03, 2020

SELL
$42.0 - $48.25 $49,686 - $57,079
-1,183 Reduced 3.71%
30,719 $1.44 Million
Q3 2019

Mar 06, 2020

SELL
$40.46 - $43.52 $50,372 - $54,182
-1,245 Reduced 3.76%
31,902 $1.36 Million
Q2 2019

Mar 02, 2020

SELL
$39.4 - $42.7 $312,836 - $339,038
-7,940 Reduced 19.32%
33,147 $1.33 Million
Q1 2019

Mar 02, 2020

BUY
$38.57 - $42.69 $150,692 - $166,789
3,907 Added 10.51%
41,087 $1.72 Million
Q4 2018

Feb 25, 2020

SELL
$37.8 - $42.69 $396,030 - $447,263
-10,477 Reduced 21.98%
37,180 $1.42 Million
Q3 2018

Feb 25, 2020

SELL
$39.75 - $42.69 $363,792 - $390,698
-9,152 Reduced 16.11%
47,657 $1.91 Million
Q2 2018

Feb 11, 2020

SELL
$39.61 - $42.76 $324,089 - $349,862
-8,182 Reduced 12.59%
56,809 $2.29 Million
Q1 2018

Jan 30, 2020

BUY
$36.18 - $40.15 $600,370 - $666,249
16,594 Added 34.29%
64,991 $2.54 Million
Q4 2017

Jan 30, 2020

BUY
$35.34 - $41.9 $1.71 Million - $2.03 Million
48,397
48,397 $1.72 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $67.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Verdence Capital Advisors LLC Portfolio

Follow Verdence Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.